 Ryan Bachtell
Concepts (242)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cocaine | 22 | 2023 | 158 | 5.900 |
Why?
| | Drug-Seeking Behavior | 7 | 2023 | 22 | 4.000 |
Why?
| | Cocaine-Related Disorders | 14 | 2023 | 107 | 3.850 |
Why?
| | Central Nervous System Stimulants | 8 | 2023 | 142 | 2.770 |
Why?
| | Methamphetamine | 5 | 2023 | 51 | 2.700 |
Why?
| | Nucleus Accumbens | 13 | 2019 | 131 | 2.620 |
Why?
| | Receptor, Adenosine A2A | 6 | 2018 | 21 | 2.530 |
Why?
| | Conditioning, Operant | 10 | 2017 | 103 | 2.270 |
Why?
| | Self Administration | 24 | 2023 | 125 | 2.090 |
Why?
| | Dopamine Uptake Inhibitors | 9 | 2016 | 53 | 1.990 |
Why?
| | Receptors, Dopamine D2 | 6 | 2018 | 87 | 1.770 |
Why?
| | Dopamine Agonists | 9 | 2018 | 30 | 1.720 |
Why?
| | Toll-Like Receptor 4 | 6 | 2023 | 330 | 1.620 |
Why?
| | Receptor, Adenosine A1 | 4 | 2014 | 11 | 1.580 |
Why?
| | Extinction, Psychological | 9 | 2023 | 81 | 1.460 |
Why?
| | Rats | 30 | 2023 | 5392 | 1.370 |
Why?
| | Rats, Sprague-Dawley | 24 | 2023 | 2478 | 1.330 |
Why?
| | Ethanol | 10 | 2016 | 575 | 1.280 |
Why?
| | Behavior, Animal | 13 | 2016 | 486 | 1.260 |
Why?
| | Caffeine | 3 | 2018 | 61 | 1.190 |
Why?
| | Receptors, AMPA | 5 | 2013 | 125 | 1.130 |
Why?
| | Adenosine A2 Receptor Agonists | 5 | 2018 | 20 | 1.110 |
Why?
| | Ventral Tegmental Area | 5 | 2019 | 43 | 1.010 |
Why?
| | Central Nervous System Depressants | 5 | 2016 | 89 | 1.000 |
Why?
| | Behavior, Addictive | 3 | 2017 | 77 | 0.970 |
Why?
| | Dose-Response Relationship, Drug | 14 | 2023 | 1945 | 0.960 |
Why?
| | Alcohol Drinking | 6 | 2016 | 652 | 0.890 |
Why?
| | Locomotion | 3 | 2018 | 83 | 0.850 |
Why?
| | Adenosine A2 Receptor Antagonists | 2 | 2018 | 11 | 0.800 |
Why?
| | Brain | 11 | 2023 | 2490 | 0.760 |
Why?
| | Reward | 5 | 2016 | 209 | 0.740 |
Why?
| | Proto-Oncogene Proteins c-fos | 9 | 2008 | 193 | 0.730 |
Why?
| | Neuroglia | 3 | 2017 | 157 | 0.720 |
Why?
| | Animals | 41 | 2023 | 33381 | 0.700 |
Why?
| | Receptors, Dopamine D1 | 4 | 2013 | 27 | 0.690 |
Why?
| | Receptors, Purinergic P1 | 2 | 2023 | 25 | 0.660 |
Why?
| | Substance-Related Disorders | 3 | 2017 | 971 | 0.620 |
Why?
| | Corticotropin-Releasing Hormone | 4 | 2016 | 77 | 0.610 |
Why?
| | Quinpirole | 5 | 2014 | 9 | 0.590 |
Why?
| | Adenosine | 6 | 2014 | 211 | 0.580 |
Why?
| | Microglia | 2 | 2019 | 221 | 0.570 |
Why?
| | Motor Activity | 9 | 2018 | 660 | 0.560 |
Why?
| | Phenethylamines | 5 | 2014 | 19 | 0.550 |
Why?
| | Astrocytes | 1 | 2017 | 177 | 0.540 |
Why?
| | Encephalitis | 1 | 2017 | 129 | 0.540 |
Why?
| | Xenobiotics | 1 | 2015 | 25 | 0.510 |
Why?
| | Pituitary-Adrenal System | 1 | 2016 | 159 | 0.500 |
Why?
| | Hypothalamo-Hypophyseal System | 1 | 2016 | 195 | 0.490 |
Why?
| | Dopamine | 6 | 2019 | 249 | 0.480 |
Why?
| | Male | 38 | 2023 | 57800 | 0.470 |
Why?
| | Analgesics, Opioid | 3 | 2023 | 793 | 0.460 |
Why?
| | Genes, fos | 2 | 2003 | 36 | 0.440 |
Why?
| | Substance Withdrawal Syndrome | 3 | 2011 | 157 | 0.430 |
Why?
| | Immunity, Innate | 1 | 2017 | 745 | 0.400 |
Why?
| | Anxiety | 1 | 2016 | 845 | 0.350 |
Why?
| | Gene Expression Regulation | 5 | 2016 | 2445 | 0.340 |
Why?
| | Naltrexone | 2 | 2023 | 80 | 0.340 |
Why?
| | Sucrose | 5 | 2016 | 104 | 0.320 |
Why?
| | Cues | 2 | 2023 | 297 | 0.290 |
Why?
| | Neural Pathways | 3 | 2008 | 277 | 0.280 |
Why?
| | Pyrimidines | 3 | 2014 | 382 | 0.270 |
Why?
| | Dopamine Antagonists | 1 | 2005 | 22 | 0.270 |
Why?
| | Aging | 1 | 2016 | 1670 | 0.270 |
Why?
| | Tegmentum Mesencephali | 1 | 2004 | 4 | 0.250 |
Why?
| | Purinergic P1 Receptor Agonists | 2 | 2014 | 8 | 0.240 |
Why?
| | Hypothermia, Induced | 1 | 2004 | 68 | 0.230 |
Why?
| | Adenosine A1 Receptor Agonists | 2 | 2014 | 2 | 0.230 |
Why?
| | Septum of Brain | 1 | 2003 | 3 | 0.230 |
Why?
| | Microinjections | 2 | 2013 | 83 | 0.220 |
Why?
| | Drinking Behavior | 2 | 2016 | 11 | 0.210 |
Why?
| | Narcotic Antagonists | 4 | 2019 | 136 | 0.210 |
Why?
| | Hypothermia | 1 | 2002 | 32 | 0.200 |
Why?
| | Excitatory Amino Acid Agonists | 2 | 2013 | 39 | 0.200 |
Why?
| | Mice, Inbred C57BL | 8 | 2004 | 4908 | 0.200 |
Why?
| | Signal Transduction | 6 | 2019 | 4709 | 0.190 |
Why?
| | Excitatory Amino Acid Antagonists | 2 | 2013 | 90 | 0.190 |
Why?
| | Immediate-Early Proteins | 1 | 2001 | 55 | 0.190 |
Why?
| | Drug Interactions | 3 | 2013 | 352 | 0.190 |
Why?
| | Pyrazoles | 2 | 2014 | 363 | 0.190 |
Why?
| | Nerve Net | 1 | 2003 | 232 | 0.180 |
Why?
| | Benzazepines | 2 | 2013 | 38 | 0.180 |
Why?
| | Alcoholism | 2 | 2003 | 717 | 0.180 |
Why?
| | Lipopolysaccharides | 1 | 2023 | 870 | 0.180 |
Why?
| | Lymphocyte Antigen 96 | 1 | 2019 | 24 | 0.180 |
Why?
| | Stress, Psychological | 2 | 2018 | 972 | 0.170 |
Why?
| | Urocortins | 3 | 2004 | 20 | 0.170 |
Why?
| | Food Preferences | 2 | 2014 | 119 | 0.170 |
Why?
| | Amygdala | 2 | 2016 | 175 | 0.170 |
Why?
| | Dorsal Raphe Nucleus | 1 | 2018 | 27 | 0.170 |
Why?
| | Serotonergic Neurons | 1 | 2018 | 24 | 0.170 |
Why?
| | Cell Count | 3 | 2004 | 315 | 0.170 |
Why?
| | Reinforcement Schedule | 2 | 2016 | 30 | 0.160 |
Why?
| | Transcription Factors | 3 | 2001 | 1570 | 0.160 |
Why?
| | Nicotine | 1 | 2001 | 276 | 0.160 |
Why?
| | Dopamine Plasma Membrane Transport Proteins | 2 | 2015 | 40 | 0.160 |
Why?
| | Interleukin-1beta | 2 | 2017 | 379 | 0.160 |
Why?
| | Immunohistochemistry | 5 | 2008 | 1691 | 0.150 |
Why?
| | Mice | 12 | 2015 | 15520 | 0.150 |
Why?
| | Immune System | 1 | 2018 | 181 | 0.150 |
Why?
| | Brain-Derived Neurotrophic Factor | 2 | 2008 | 117 | 0.150 |
Why?
| | Gastrointestinal Microbiome | 1 | 2023 | 548 | 0.150 |
Why?
| | Opioid-Related Disorders | 1 | 2023 | 417 | 0.140 |
Why?
| | Neuronal Plasticity | 2 | 2008 | 219 | 0.140 |
Why?
| | Gene Transfer Techniques | 3 | 2013 | 154 | 0.140 |
Why?
| | TRPC Cation Channels | 1 | 2016 | 11 | 0.140 |
Why?
| | Microbiota | 1 | 2023 | 656 | 0.140 |
Why?
| | Neurons | 4 | 2015 | 1345 | 0.140 |
Why?
| | Paraventricular Hypothalamic Nucleus | 1 | 2016 | 36 | 0.140 |
Why?
| | Dopaminergic Neurons | 1 | 2016 | 43 | 0.130 |
Why?
| | Phosphorylation | 4 | 2013 | 1633 | 0.130 |
Why?
| | Brain Chemistry | 2 | 2008 | 119 | 0.130 |
Why?
| | Adrenocorticotropic Hormone | 1 | 2016 | 152 | 0.130 |
Why?
| | Receptors, Adenosine A2 | 1 | 2014 | 5 | 0.130 |
Why?
| | Corticosterone | 1 | 2016 | 253 | 0.120 |
Why?
| | RNA, Messenger | 3 | 2017 | 2657 | 0.120 |
Why?
| | Analysis of Variance | 3 | 2012 | 1293 | 0.120 |
Why?
| | DNA-Binding Proteins | 1 | 2001 | 1346 | 0.120 |
Why?
| | 6-Cyano-7-nitroquinoxaline-2,3-dione | 1 | 2013 | 4 | 0.120 |
Why?
| | alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 2013 | 17 | 0.120 |
Why?
| | Central Nervous System | 1 | 2015 | 245 | 0.110 |
Why?
| | Adenosine Deaminase Inhibitors | 1 | 2012 | 2 | 0.110 |
Why?
| | Adenosine Kinase | 1 | 2012 | 2 | 0.110 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 2 | 2011 | 160 | 0.110 |
Why?
| | Gene Expression | 2 | 2018 | 1489 | 0.110 |
Why?
| | Stimulation, Chemical | 1 | 2012 | 59 | 0.110 |
Why?
| | Adenosine Deaminase | 1 | 2012 | 25 | 0.110 |
Why?
| | Mice, Inbred DBA | 2 | 2003 | 174 | 0.110 |
Why?
| | Purinergic P2X Receptor Antagonists | 1 | 2011 | 6 | 0.110 |
Why?
| | Xanthines | 1 | 2011 | 15 | 0.110 |
Why?
| | Disease Models, Animal | 3 | 2011 | 3730 | 0.100 |
Why?
| | Receptor, trkB | 2 | 2008 | 28 | 0.100 |
Why?
| | Morpholines | 1 | 2012 | 106 | 0.100 |
Why?
| | Sweetening Agents | 1 | 2011 | 52 | 0.100 |
Why?
| | Age Factors | 2 | 2018 | 2995 | 0.100 |
Why?
| | Naloxone | 3 | 2019 | 98 | 0.100 |
Why?
| | Neostriatum | 1 | 2011 | 30 | 0.100 |
Why?
| | Recurrence | 1 | 2014 | 975 | 0.100 |
Why?
| | Association Learning | 1 | 2011 | 59 | 0.100 |
Why?
| | Tissue Distribution | 2 | 2002 | 334 | 0.090 |
Why?
| | Genetic Vectors | 2 | 2008 | 302 | 0.090 |
Why?
| | Tyrosine 3-Monooxygenase | 2 | 2016 | 70 | 0.090 |
Why?
| | MAP Kinase Signaling System | 1 | 2011 | 292 | 0.090 |
Why?
| | Social Environment | 1 | 2011 | 294 | 0.080 |
Why?
| | Presynaptic Terminals | 1 | 2008 | 58 | 0.080 |
Why?
| | Impulsive Behavior | 1 | 2008 | 105 | 0.080 |
Why?
| | Drug Tolerance | 1 | 2007 | 78 | 0.080 |
Why?
| | Hippocampus | 2 | 2003 | 735 | 0.080 |
Why?
| | Glutamic Acid | 1 | 2008 | 224 | 0.070 |
Why?
| | Anesthetics, Local | 1 | 2007 | 85 | 0.070 |
Why?
| | Synaptic Transmission | 1 | 2008 | 239 | 0.070 |
Why?
| | Frontal Lobe | 1 | 2007 | 148 | 0.070 |
Why?
| | Cyclic AMP | 1 | 2007 | 242 | 0.070 |
Why?
| | Humans | 6 | 2023 | 118969 | 0.070 |
Why?
| | Salicylamides | 1 | 2005 | 3 | 0.070 |
Why?
| | Morphine | 2 | 2008 | 134 | 0.070 |
Why?
| | Tetrahydronaphthalenes | 1 | 2005 | 32 | 0.070 |
Why?
| | Prefrontal Cortex | 1 | 2008 | 275 | 0.060 |
Why?
| | Quinine | 1 | 2004 | 12 | 0.060 |
Why?
| | Pupil | 1 | 2004 | 13 | 0.060 |
Why?
| | Body Temperature | 1 | 2004 | 215 | 0.060 |
Why?
| | Female | 4 | 2023 | 61564 | 0.060 |
Why?
| | Crosses, Genetic | 1 | 2003 | 138 | 0.060 |
Why?
| | Brain Diseases | 1 | 2004 | 140 | 0.060 |
Why?
| | Cognition Disorders | 1 | 2007 | 529 | 0.060 |
Why?
| | Aminoacetonitrile | 1 | 2002 | 1 | 0.060 |
Why?
| | Chlordiazepoxide | 1 | 2002 | 1 | 0.060 |
Why?
| | Yohimbine | 1 | 2002 | 9 | 0.060 |
Why?
| | Pregnanolone | 1 | 2002 | 21 | 0.050 |
Why?
| | Body Temperature Regulation | 1 | 2003 | 73 | 0.050 |
Why?
| | Haloperidol | 1 | 2002 | 36 | 0.050 |
Why?
| | Mice, Inbred Strains | 1 | 2003 | 405 | 0.050 |
Why?
| | Time Factors | 3 | 2012 | 6412 | 0.050 |
Why?
| | Cold Temperature | 1 | 2003 | 132 | 0.050 |
Why?
| | Down-Regulation | 2 | 2018 | 627 | 0.050 |
Why?
| | Protease Inhibitors | 1 | 2002 | 102 | 0.050 |
Why?
| | Chromosome Mapping | 1 | 2003 | 510 | 0.050 |
Why?
| | Norepinephrine | 1 | 2002 | 212 | 0.050 |
Why?
| | Early Growth Response Protein 1 | 1 | 2001 | 31 | 0.050 |
Why?
| | Pentobarbital | 1 | 2000 | 16 | 0.050 |
Why?
| | Hot Temperature | 1 | 2003 | 334 | 0.050 |
Why?
| | Exploratory Behavior | 1 | 2001 | 90 | 0.050 |
Why?
| | Species Specificity | 1 | 2002 | 565 | 0.050 |
Why?
| | Temperature | 1 | 2003 | 622 | 0.050 |
Why?
| | Drug Combinations | 1 | 2001 | 291 | 0.050 |
Why?
| | Drug Administration Schedule | 1 | 2002 | 736 | 0.040 |
Why?
| | Child | 1 | 2018 | 19129 | 0.040 |
Why?
| | Organic Cation Transport Proteins | 1 | 2018 | 28 | 0.040 |
Why?
| | Reaction Time | 2 | 2012 | 392 | 0.040 |
Why?
| | Receptor, Serotonin, 5-HT1A | 1 | 2018 | 39 | 0.040 |
Why?
| | Tryptophan Hydroxylase | 1 | 2018 | 52 | 0.040 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2003 | 709 | 0.040 |
Why?
| | Serotonin Plasma Membrane Transport Proteins | 1 | 2018 | 73 | 0.040 |
Why?
| | Rats, Long-Evans | 2 | 2008 | 105 | 0.040 |
Why?
| | Molecular Dynamics Simulation | 1 | 2019 | 213 | 0.040 |
Why?
| | Sex Factors | 1 | 2003 | 1781 | 0.040 |
Why?
| | Cerebral Cortex | 1 | 2001 | 416 | 0.040 |
Why?
| | Sex Characteristics | 1 | 2002 | 671 | 0.040 |
Why?
| | Rats, Transgenic | 1 | 2016 | 14 | 0.040 |
Why?
| | Maze Learning | 1 | 2016 | 86 | 0.030 |
Why?
| | Rats, Inbred F344 | 1 | 2016 | 245 | 0.030 |
Why?
| | Membrane Potentials | 1 | 2016 | 253 | 0.030 |
Why?
| | NF-kappa B | 1 | 2019 | 670 | 0.030 |
Why?
| | Phenotype | 1 | 2003 | 3003 | 0.030 |
Why?
| | Mice, Inbred C3H | 1 | 2015 | 250 | 0.030 |
Why?
| | Drug Administration Routes | 1 | 2012 | 42 | 0.030 |
Why?
| | Microdialysis | 1 | 2012 | 65 | 0.030 |
Why?
| | Pain Threshold | 1 | 2012 | 69 | 0.030 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2012 | 95 | 0.030 |
Why?
| | Hyperalgesia | 1 | 2012 | 108 | 0.030 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2012 | 173 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2012 | 1206 | 0.020 |
Why?
| | Narcotics | 1 | 2008 | 50 | 0.020 |
Why?
| | Integrases | 1 | 2008 | 123 | 0.020 |
Why?
| | Adenoviridae | 1 | 2008 | 191 | 0.020 |
Why?
| | Synapsins | 1 | 2007 | 13 | 0.020 |
Why?
| | Models, Molecular | 1 | 2012 | 1435 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2012 | 2025 | 0.020 |
Why?
| | Dronabinol | 1 | 2008 | 121 | 0.020 |
Why?
| | MAP Kinase Kinase 1 | 1 | 2007 | 67 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2015 | 4077 | 0.020 |
Why?
| | Hallucinogens | 1 | 2008 | 74 | 0.020 |
Why?
| | Protein Binding | 1 | 2012 | 1975 | 0.020 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2007 | 175 | 0.020 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2007 | 144 | 0.020 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2007 | 140 | 0.020 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2007 | 191 | 0.020 |
Why?
| | Protein Kinase C | 1 | 2007 | 297 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2007 | 770 | 0.020 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2007 | 159 | 0.020 |
Why?
| | Mutation | 1 | 2015 | 3457 | 0.020 |
Why?
| | Neuropsychological Tests | 1 | 2007 | 1032 | 0.010 |
Why?
| | Neurotransmitter Agents | 1 | 2003 | 76 | 0.010 |
Why?
| | Genes, Immediate-Early | 1 | 2001 | 17 | 0.010 |
Why?
| | Mice, Knockout | 1 | 2007 | 2680 | 0.010 |
Why?
| | Cognition | 1 | 2008 | 1024 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2007 | 1597 | 0.010 |
Why?
| | Anesthetics | 1 | 2000 | 58 | 0.010 |
Why?
| | Brain Mapping | 1 | 2003 | 532 | 0.010 |
Why?
| | Stress, Physiological | 1 | 2000 | 415 | 0.010 |
Why?
| | Carrier Proteins | 1 | 2000 | 726 | 0.010 |
Why?
| | Bacterial Proteins | 1 | 2000 | 759 | 0.010 |
Why?
| | Membrane Proteins | 1 | 2000 | 1055 | 0.010 |
Why?
|
|
Bachtell's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|